Search - tctmd.com

Displaying 401 - 420 of 692

Sort: Relevancy | Date

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

Presenter: John S. Douglas Jr, Valerian Fernandes, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

High-grade AV Block After ASA

Presenter: John S. Douglas Jr, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Might Mitraclip Make Ablation Irrelevant?

Presenter: John S. Douglas Jr, Valerian Fernandes, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Evaluation and Management of AS With Obstructive HCM

Presenter: John S. Douglas Jr, Valerian Fernandes, Srihari S. Naidu

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

When to Declare Victory

Presenter: John S. Douglas Jr, Valerian Fernandes, Christopher D. Nielsen

October 30, 2017

Presentation TCT 2017

My Worst Complication(s)

Presenter: John S. Douglas Jr, Valerian Fernandes, George S. Hanzel

October 30, 2017

Presentation TCT 2017

My Most Difficult Case(s)

Presenter: John S. Douglas Jr, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Presenter: David H. Adams, Ted Feldman, Gilles Dreyfus

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Is Ventricular Arrhythmia After Ablation a Real Phenomenon?

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

Preprocedural and Intraprocedural Imaging to Guide Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Presentation TCT 2017

Contemporary Alcohol Septal Ablation Techniques

Presenter: Srihari S. Naidu, Paul Sorajja, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Patient Selection for Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2017

Advertisement

The Inflammatory Hypothesis After CANTOS: CIRT

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

High-grade AV Block After ASA

Might Mitraclip Make Ablation Irrelevant?

Should Alleviating ISCHEMIA Be the Goal?

Evaluation and Management of AS With Obstructive HCM

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

When to Declare Victory

My Worst Complication(s)

My Most Difficult Case(s)

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Is Ventricular Arrhythmia After Ablation a Real Phenomenon?

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Preprocedural and Intraprocedural Imaging to Guide Ablation

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Contemporary Alcohol Septal Ablation Techniques

Patient Selection for Alcohol Septal Ablation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content